Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › tazobactam

tazobactam

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of tazobactam

2 trials tracked of tazobactam: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 234 citations.

2Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 1
  1. Phase 3 Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Completed · 234 cited
  2. Phase 2 Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Feasibility study for meropenem versus piperacillin/tazobactam in sepsis shows 30.5% 30-day mortality
Infectious Disease RCT
Feasibility study for meropenem versus piperacillin/tazobactam in sepsis shows 30.5% 30-day mortality Trial Tests Meropenem for Treatment of Sepsis in Critical Care
This feasibility study of 200 critically ill adults with sepsis in 10 Danish ICUs evaluated the trial's operational viability. The study rep…
A new feasibility study explores the use of meropenem to treat critically ill adults suffering from sepsis in intensive care units.
Oct 4, 2026